Fatal Disseminated Strongyloidiasis in an Immunosuppressed Patient During COVID-19 Pandemic
Introduction This report presents a fatal case of disseminated strongyloidiasis in a patient with myasthenia gravis and diabetes mellitus who had received corticosteroid therapy. Case Report The patient was a 67-year-old woman living in a rural area endemic for Strongyloides stercoralis in northern Iran. Disseminated strongyloidiasis was diagnosed in the advanced stage of the disease, with enormous numbers of larvae demonstrated in direct smears prepared from stool samples and stomach biopsy. Despite treatment with ivermectin and antibiotics, the patient succumbed to the severity of the infection. Conclusion Clinicians working in endemic areas should be mindful of the possibility of gastric involvement in strongyloidiasis, even if symptoms are nonspecific. We recommend that high-risk individuals be screened for S. stercoralis prior to immunosuppressive therapy in endemic regions to raise awareness and prevent similar cases..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
|---|---|
| Enthalten in: |
Acta parasitologica - 68(2023), 3 vom: 02. Aug., Seite 711-717 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Soleymani, Eissa [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Disseminated strongyloidiasis |
|---|
| Anmerkungen: |
© The Author(s) under exclusive licence to Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2023 |
|---|
| doi: |
10.1007/s11686-023-00705-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2145268553 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2145268553 | ||
| 003 | DE-627 | ||
| 005 | 20240118103626.0 | ||
| 007 | tu | ||
| 008 | 240118s2023 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11686-023-00705-x |2 doi | |
| 035 | |a (DE-627)OLC2145268553 | ||
| 035 | |a (DE-He213)s11686-023-00705-x-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 610 |q VZ |
| 082 | 0 | 4 | |a 570 |a 610 |q VZ |
| 084 | |a 12 |2 ssgn | ||
| 100 | 1 | |a Soleymani, Eissa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fatal Disseminated Strongyloidiasis in an Immunosuppressed Patient During COVID-19 Pandemic |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s) under exclusive licence to Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2023 | ||
| 520 | |a Introduction This report presents a fatal case of disseminated strongyloidiasis in a patient with myasthenia gravis and diabetes mellitus who had received corticosteroid therapy. Case Report The patient was a 67-year-old woman living in a rural area endemic for Strongyloides stercoralis in northern Iran. Disseminated strongyloidiasis was diagnosed in the advanced stage of the disease, with enormous numbers of larvae demonstrated in direct smears prepared from stool samples and stomach biopsy. Despite treatment with ivermectin and antibiotics, the patient succumbed to the severity of the infection. Conclusion Clinicians working in endemic areas should be mindful of the possibility of gastric involvement in strongyloidiasis, even if symptoms are nonspecific. We recommend that high-risk individuals be screened for S. stercoralis prior to immunosuppressive therapy in endemic regions to raise awareness and prevent similar cases. | ||
| 650 | 4 | |a Disseminated strongyloidiasis | |
| 650 | 4 | |a Immunosuppressive therapy | |
| 650 | 4 | |a Myasthenia gravis | |
| 700 | 1 | |a Davoodi, Lotfollah |4 aut | |
| 700 | 1 | |a Shayesteh Azar, Shadi |4 aut | |
| 700 | 1 | |a Mirbadiei, Seyed Reza |4 aut | |
| 700 | 1 | |a Parandin, Fatemeh |4 aut | |
| 700 | 1 | |a Azimi, Afshin |4 aut | |
| 700 | 1 | |a Mizani, Azadeh |4 aut | |
| 700 | 1 | |a Khorshidvand, Zohreh |4 aut | |
| 700 | 1 | |a Fakhar, Mahdi |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta parasitologica |d Springer International Publishing, 1992 |g 68(2023), 3 vom: 02. Aug., Seite 711-717 |w (DE-627)13115690X |w (DE-600)1132735-2 |w (DE-576)040093867 |x 1230-2821 |7 nnns |
| 773 | 1 | 8 | |g volume:68 |g year:2023 |g number:3 |g day:02 |g month:08 |g pages:711-717 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11686-023-00705-x |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-VET | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_4277 | ||
| 951 | |a AR | ||
| 952 | |d 68 |j 2023 |e 3 |b 02 |c 08 |h 711-717 | ||